Hampstead Capital LLP PFE Holdings History
Number of Shares
89,200.00
Current Holdings Value*
$3.93 Mil
% of Portfolio
7.04%
Total Estimate Gain
$-907,112.00
% of Total Estimate Gain
-24.43%
Hampstead Capital LLP's Pfizer Inc Holding Summary
As of 2018-09-30, Hampstead Capital LLP held 89,200.00 shares of Pfizer Inc(PFE), totaling $3.93 Mil. This investment constitutes 7.04% of their stock portfolio, and Hampstead Capital LLP now holds 0% of the outstanding Pfizer Inc(PFE) stock.
The initial trade took place in 2018Q2. In addition, there have been 2 sales at an average price of $40.58 for 13,900.00 shares. Based on historical transaction data and PFE's current price of $25.14, Hampstead Capital LLP's estimated gain on his PFE holdings is $-907,112.00, reflecting a -24.43% gain to date.
Hampstead Capital LLP PFE ($25.14) Holding Chart
Hampstead Capital LLP PFE ($25.14) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers